-
Abstract: The incidence of invasive fungal sinusitis is low, on the rising in recent years.But the misdiagnosis rate of the disease is high.In order to improve the level of early diagnosis and reduce the misdiagnosis, in this paper, the invasive fungal sinusitis's clinical characteristics, diagnosis, treatment and prognosis are reviewed.
-
-
[1] DENNING D W.Invasive aspergillosis[J]. Clin Infect Dis,1998,26:781-805.
[2] TAKAHASHI H, HINOHIRA Y, HATO N, et al. Clinical features and outcomes of four patients with invasive fungal sinusitis[J]. Auris Nasus Larynx,2011,38:289-294.
[3] 唐隽,于青青,张超,等. 慢性侵袭型真菌性鼻窦炎1例报道并文献复习[J]. 国际耳鼻咽喉头颈外科杂志,2012,36(2):116-118.
[4] MORPETH J F, RUPP N T, DOLEN W K, et al. Fungal sinusitis:an update[J]. Ann Allergy Asthma Immunol,1996,76:128-140.
[5] DESHAZO R D, O'BRIEN M, CHAPIN K, et al. A new classification and diagnostic criteria for invasive fungal sinusitis[J].Arch Otolaryngol Head Neck Surg,1997,123:1181-1188.
[6] ARIBANDI M, MCCOY V A, BAZAN C 3rd. Imaging features of invasive and noninvasive fungal sinusitis:a review[J].Radiographics,2007,27:1283-1296.
[7] RICHARDSON M. The ecology of the Zygomyceles and its impact on environmental exposure[J]. Clin Microbiol infect,2009,15:2-9.
[8] LEE S Y, YEO C L, LEE W H, et al. Prevalence of invasive fungal disease in hematological patients at a tertiary university hospital in Singapore[J]. BMC Res Notes, 2011, 4:42-45.
[9] HE C Y, PIAO Y S, TIAN C,et al. Clinicopathologic study of invasive fungal rhinosinusitis caused by Aspergillus and Mucorales[J].Zhonghua Bing Li Xue Za zhi,2012,41:662-666.
[10] DE SHAZO R D, CHAPIN K, SWAIN R E. Fungal sinusitis[J]. N Engl J Med,1997,337:254-259.
[11] DE CARPENTIER J P, RAMAMURTHY L, DENNING D W, et al. An algorithmic approach to aspergillus sinusitis[J]. J Laryngol Otol,1994,108:314-318.
[12] 李源,李永奇. 慢性侵袭性真菌性鼻-鼻窦炎[J]. 国外医学耳鼻咽喉科学分册[J]. 2005,9(2):123-125.
[13] 杨本涛,王振常,刘莎,等.慢性侵袭性真菌性鼻窦炎的CT和MRI诊断[J].中华放射学杂志,2005,39(8):826-830.
[14] LUND V J, LLOYD G, SAVY L, et al. Fungal rhinosinusitis[J]. J Laryngol Otol,2000,114:76-80.
[15] 李永奇,李源. 改良Gomori六胺银染色法诊断慢性侵袭型真菌性鼻及鼻窦炎[J].中国耳鼻咽喉头颈外科,2007,14(5):317-318.
[16] DENNING D W. Therapeutic outcome in invasive aspergillosis[J].Clin infect Dis,1996,23:608-615.
[17] BURCH P A1, KARP J E, MERZ W G,et al. Favorable outcome of invasive aspergillosis in patients with acute leukemia[J].J Clinl Oncol,1987,5:1985-1993.
[18] FISHER M A,TALBT G H, MAISLIN G, et al. Risk factors for Amphotericin B-associated nephrotoxicity[J].Am J Med,1989,87:547-552.
[19] TALBOT G H, HUANG A, PROVENCHER M.Invasive aspergillus rhinosinusitis in patients with acute leukemia[J].Rev Infect Dis,1991,13:219-232.
[20] DENNING D W, LEE J Y, HOSTETLER J S,et al. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy of Invasive Aspergillosis[J].Am J Med,1994,97:135-144.
[21] WASHBURN R G, KENNEDY D W, BEGLEY M G, et al.Chronic fungal sinusitis in apparently normal hosts[J].Medicine(Baltimore),1988,67:231-247.
[22] LI Y,LI Y, LI P, et al. Diagnosis and endoscopic surgery of chronic invasive fungal rhinosinusitis[J].Am J Rhinol Allergy,2009,23:622-625.
[23] KHOO S H, DENNING D W.Cure of chronic invasive sinus aspergillosis with oral saperconazole[J].J Med Vet Mycol,1995,33:63-66.
[24] DENNING D W, HANSON L H, STEVENS D A. In vitro activity of saperconazole(R66905) compared with amphotericin B and itraconazole against Aspergillus species[J].Eur J Clin Microbiol Infect Dis,1990,9:693-697.
[25] VAN CUTSEM J, VAN GERVEN F, JANSSEN P A.Oral and parenteral therapy with saperconazole(R66905) of invasive aspergillosis in normal and immunocompromised animals[J].Antimicrob Agents Chemother,1989,33:2063-2068.
[26] ROMETT J L,NEWMAN R K. Aspergillosis of the nose and paranasal sinuses[J]. Laryngoscope,1982,92:764-766.
[27] IWEN P C, REED E C, ARMITAGE J O, et al. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants[J]. Infection Control Hosp Epidemiol,1993,14:131-139.
[28] SOHAIL M A, AL KHABORI M, HYDER J, et al. Acute fulminant fungal sinusitis:clinical presentation, radiological findings and treatment[J]. Acta Trop, 2001, 80:177-185.
[29] SPELLBERG B,EDWARDS J,IBRAHIM A. Novel perspectives on mucormycosis:pathophysiology, presentation, and management[J].Clin Microbiol Rev,2005,18:556-569.
[30] SINGER M S,SEIBEL N L,VEZINA G, et al.Successful treatment of invasive aspergillosis in two patients with acute myelogenous leukemia[J]. J Pediatr hematol Oncol,2003,25:252-256.
[31] OTTO K J, DELGAUDIO J M. Invasive fungal rhinosinusitis:What is the appropriate follow-up[J]? Ame J Rhinol,2006,20:582-585.
[32] DE MARIE S, JANKNEGT R, BAKKER-WOUDE-NBERG I A.Clinical use of liposomal and lipid-complexed amphotericin B[J].J Antimicrob Chemother,1994,33:907-916.
[33] DENNING D W. Aspergillosis:diagnosis and treatment[J]. Int J Antimicrob Agents,1996,6:161-168.
[34] ANDRIOLE V T. Aspergillus infections:problems in diagnosis and treatment[J]. Infect Agents Dis, 1996,5:47-54.
-
计量
- 文章访问数: 79
- PDF下载数: 63
- 施引文献: 0